COMMUNIQUÉS West-GlobeNewswire

Major shareholder announcement - BlackRock, Inc.
16/09/2026
16 September 2026 ANNOUNCEMENT NO. 315 Major shareholder announcement - BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that [...]
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
16/09/2026
DENVER, Sept. 16, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) executives put even more personal capital behind the company, following positive Phase 2a results for its [...]
Gautham Chidambaram Announces New QP & Half-Pound THCA Flower Sizing at Passion Farms
16/09/2026
Passion Farms just made it easier for wholesale buyers to try new strains-rolling out QP and half-pound THCA flower sizes across TX, CA & OK, no more pound minimums. HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- [...]
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
16/09/2026
Collaboration with leading 22-location interventional pain practice supports Milestone’s longer-term reimbursement strategy ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: [...]
NeuroSigma Expands Payment Options for the Monarch eTNS® System
16/09/2026
Families prescribed Monarch can now pay with digital wallets or third-party installment plans at checkout LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced expanded payment options for [...]
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
16/09/2026
Total national coverage footprint for PENFS increases to over 120 million covered lives CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical [...]
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
16/09/2026
HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (NYSE: IBO) (the “ Company ” or “ Impact ”) announced that a Form F-4 registration statement (the “ Registration Statement ”) was filed with the U.S. [...]
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
16/09/2026
MINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc. ("PetVivo"), in cooperation with its parent, PetVivo Holdings, Inc. (OTCQX: PETV), and its other subsidiaries, Somatrix Technologies, Inc. and [...]
NEXGEL Announces Date for Investor Update Call
16/09/2026
LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians [...]
X-Chem Named First Winner of Chordoma Foundation TBXT Challenge with Discovery of Novel Binder for Untreatable Bone Cancer Target
16/09/2026
Groundbreaking synergy of DEL screening and computational chemistry yields the first compound to meet the TBXT Challenge’s submicromolar binding threshold for brachyury (TBXT) WALTHAM, Mass., Sept. 16, 2026 (GLOBE [...]
Dr. Peter Goldman Returns to the Bay Area, Bringing Zone Technique and a Distinct Approach to Healing to Berkeley, CA
16/09/2026
Founder of Zone School of Healing Uses the Zone Technique to Balance the Body’s Six Main Systems, Helping Clients Pursue Healing at the Highest Level BERKELEY, CA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- After nearly a [...]
Abalos Therapeutics Publishes Two Articles in Viruses Further Validating its AdaptInnate Approach to Treat Solid Tumors
16/09/2026
Preclinical findings further strengthen the scientific foundation for Abalos’ AdaptInnate approach, which leverages systemically administered non-lytic arenaviruses to selectively target solid tumors by triggering body- [...]
Kailera Therapeutics to Participate in September Investor Conferences
16/09/2026
WALTHAM, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/09/2026
WATERTOWN, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases [...]
AAVantgarde to Showcase Clinical Progress in Usher 1B and Stargardt Disease at EURetina 2026
16/09/2026
MILAN, Sept. 16, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), the clinical-stage biotechnology company developing genetic medicines for inherited retinal diseases (IRDs) using its proprietary dual-AAV [...]
Shock Top and Spirit Halloween Brew Up a Scary Good Collaboration
16/09/2026
Limited-Edition Candy Corn Wheat Ale Craft Beer and Spirit Halloween-Exclusive Wedgehead Costume Bring Big Flavor, Big Fun, and Head-Turning Halloween Energy to Fans Nationwide PORTLAND, Ore., Sept. 16, 2026 (GLOBE [...]
NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference
16/09/2026
CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating [...]
Sironax Announces Option Exercise and Asset Purchase
16/09/2026
Novartis exercises option to acquire Sironax’s brain delivery platform Sironax to advance three clinical-stage programs and multiple early-stage candidates using purchase proceeds Sironax to retain development rights to [...]
Coave Therapeutics Strengthens Leadership Team to Advance Lead Gene Therapy Program into the Clinic
16/09/2026
Senior appointments add world-class expertise across gene therapy development, ophthalmology, CMC, regulatory affairs and global operations to support the next phase of growth Carl De Luca, PhD, appointed Chief [...]

Pages